Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Novavax, Canada finalize purchase agreement on COVID vaccine » 17:24 01/22/21 01/22 17:24 01/22/21 17:24 NVAX Novavax $126.99 / +4.78 (+3.91%) Novavax announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVAX Novavax $126.99 / +4.78 (+3.91%) 01/15/21 Novavax appoints Henrietta Ukwu as chief regulatory, quality officer 01/11/21 Baxter announces sterile manufacturing agreement for Novavax COVID-19 vaccine 01/07/21 Novavax completes agreement with Australia for 51M doses of COVID-19 vaccine 12/28/20 Novavax announces initiation of PREVENT-19 Phase 3 efficacy trial NVAX Novavax $126.99 / +4.78 (+3.91%) 12/29/20 B. Riley Securities Novavax selloff yesterday brings 'compelling' opportunity, says B. Riley 12/28/20 JPMorgan JPMorgan sees data from Novavax vaccine trial in U.S. in March/April 12/14/20 Jefferies Novavax initiated with a Buy at Jefferies 12/07/20 B. Riley Securities Arcturus Therapeutics price target raised to $111 from $64 at B. Riley NVAX Novavax $126.99 / +4.78 (+3.91%) 11/09/20 Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73 08/14/20 Novavax says UK to purchase 60M doses of NVX-CoV2373 vaccine candidate 08/10/20 Novavax reports Q2 EPS (30c), consensus (42c) NVAX Novavax $126.99 / +4.78 (+3.91%) 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 11/04/20 Novovax, Pfizer secure vaccine agreements with Australia, SMH reports 10/20/20 Novavax vaccine shows 'strong' B-, T-cell response, Science Magazine reports 10/02/20 White House officials raise objections to FDA vaccine approval plans, WSJ says NVAX Novavax $126.99 / +4.78 (+3.91%) 12/28/20 Fly Intel: Wall Street's top stories for Monday 12/28/20 Fly Intel: Wall Street's top stories at midday 11/30/20 Fly Intel: Pre-market Movers 11/27/20 Fly Intel: Wall Street's top stories for Friday NVAX Novavax $126.99 / +4.78 (+3.91%) 11/27/20 Unusually active option classes on open November 27th 11/13/20 Novavax call volume above normal and directionally bullish 11/12/20 Novavax call volume above normal and directionally bullish 10/20/20 Novavax call volume above normal and directionally bullish
Periodicals	AstraZeneca to slash EU COVID-19 vaccine deliveries by 60% in Q1, Reuters says » 15:25 01/22/21 01/22 15:25 01/22/21 15:25 AZN AstraZeneca $53.21 / +0.68 (+1.29%) AstraZeneca has informed… AstraZeneca has informed European Union officials that it would reduce deliveries of its coronavirus vaccine to the bloc by 60% to 31M doses in the first quarter of 2021 due to production issues, Reuters' Francesco Guarascio reports, citing a senior official. The company was forecast to deliver to the 27 EU countries roughly 80M shots by the end of March, the author notes, citing the official who was involved in the talks. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $53.21 / +0.68 (+1.29%) 01/20/21 AstraZeneca's Enhertu approved in EU for HER2-positive metastatic breast cancer 01/18/21 AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer 01/15/21 Aveo Pharmaceuticals announces results from portion of DEDUCTIVE trial 01/15/21 AstraZeneca's Imfinzi approved in E.U. and U.K. for additional dosing in NSCLC AZN AstraZeneca $53.21 / +0.68 (+1.29%) 15:00 Today Barclays AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 01/15/21 Berenberg AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg 01/15/21 Fly Intel: Top five analyst initiations AZN AstraZeneca $53.21 / +0.68 (+1.29%) 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year 07/30/20 AstraZeneca backs FY20 mid- to high-teens percentage increase in core EPS 07/30/20 AstraZeneca reports Q2 core EPS 96c, up 31% at CER AZN AstraZeneca $53.21 / +0.68 (+1.29%) 11:53 Today EU to see delay of AstraZeneca COVID vaccine delivery, FT reports 10:38 Today AstraZeneca informs EU Commission of vaccine delivery issues, Bild says 01/17/21 Pakistan approves AstraZeneca COVID vaccine for emergency use, Reuters says 01/15/21 AstraZeneca's COVISHIELD vaccine approved by Nepal, Reuters reports AZN AstraZeneca $53.21 / +0.68 (+1.29%) 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/20/21 PDUFA Date for Tagrisso (Osimertinib) 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $53.21 / +0.68 (+1.29%) 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th 12/28/20 Unusually active option classes on open December 28th 12/14/20 AstraZeneca call volume above normal and directionally bullish
Recommendations	AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays » 15:00 01/22/21 01/22 15:00 01/22/21 15:00 AZN AstraZeneca $53.30 / +0.77 (+1.47%) Barclays analyst Emmanuel… Barclays analyst Emmanuel Papadakis lowered the firm's price target on AstraZeneca to 9,000 GBp from 9,300 GBp and keeps an Overweight rating on the shares. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $53.30 / +0.77 (+1.47%) 01/20/21 AstraZeneca's Enhertu approved in EU for HER2-positive metastatic breast cancer 01/18/21 AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer 01/15/21 Aveo Pharmaceuticals announces results from portion of DEDUCTIVE trial 01/15/21 AstraZeneca's Imfinzi approved in E.U. and U.K. for additional dosing in NSCLC AZN AstraZeneca $53.30 / +0.77 (+1.47%) 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 01/15/21 Berenberg AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Deutsche Bank AstraZeneca initiated with a Buy at Deutsche Bank AZN AstraZeneca $53.30 / +0.77 (+1.47%) 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year 07/30/20 AstraZeneca backs FY20 mid- to high-teens percentage increase in core EPS 07/30/20 AstraZeneca reports Q2 core EPS 96c, up 31% at CER AZN AstraZeneca $53.30 / +0.77 (+1.47%) 11:53 Today EU to see delay of AstraZeneca COVID vaccine delivery, FT reports 10:38 Today AstraZeneca informs EU Commission of vaccine delivery issues, Bild says 01/17/21 Pakistan approves AstraZeneca COVID vaccine for emergency use, Reuters says 01/15/21 AstraZeneca's COVISHIELD vaccine approved by Nepal, Reuters reports AZN AstraZeneca $53.30 / +0.77 (+1.47%) 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/20/21 PDUFA Date for Tagrisso (Osimertinib) 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $53.30 / +0.77 (+1.47%) 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th 12/28/20 Unusually active option classes on open December 28th 12/14/20 AstraZeneca call volume above normal and directionally bullish
Periodicals	EU to see delay of AstraZeneca COVID vaccine delivery, FT reports » 11:53 01/22/21 01/22 11:53 01/22/21 11:53 AZN AstraZeneca $53.07 / +0.54 (+1.03%) The European Union will… The European Union will experience a delay in the delivery of COVID-19 vaccines made by AstraZeneca in partnership with Oxford, the Financial Times reports. The company said that initial volumes of the vaccine will be "lower than originally anticipated," the report says. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $53.07 / +0.54 (+1.03%) 01/20/21 AstraZeneca's Enhertu approved in EU for HER2-positive metastatic breast cancer 01/18/21 AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer 01/15/21 Aveo Pharmaceuticals announces results from portion of DEDUCTIVE trial 01/15/21 AstraZeneca's Imfinzi approved in E.U. and U.K. for additional dosing in NSCLC AZN AstraZeneca $53.07 / +0.54 (+1.03%) 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 01/15/21 Berenberg AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Deutsche Bank AstraZeneca initiated with a Buy at Deutsche Bank AZN AstraZeneca $53.07 / +0.54 (+1.03%) 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year 07/30/20 AstraZeneca backs FY20 mid- to high-teens percentage increase in core EPS 07/30/20 AstraZeneca reports Q2 core EPS 96c, up 31% at CER AZN AstraZeneca $53.07 / +0.54 (+1.03%) 10:38 Today AstraZeneca informs EU Commission of vaccine delivery issues, Bild says 01/17/21 Pakistan approves AstraZeneca COVID vaccine for emergency use, Reuters says 01/15/21 AstraZeneca's COVISHIELD vaccine approved by Nepal, Reuters reports 01/03/21 AstraZeneca/Oxford COVID vaccine authorized by India, WSJ reports AZN AstraZeneca $53.07 / +0.54 (+1.03%) 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/20/21 PDUFA Date for Tagrisso (Osimertinib) 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $53.07 / +0.54 (+1.03%) 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th 12/28/20 Unusually active option classes on open December 28th 12/14/20 AstraZeneca call volume above normal and directionally bullish
Periodicals	AstraZeneca informs EU Commission of vaccine delivery issues, Bild says » 10:38 01/22/21 01/22 10:38 01/22/21 10:38 AZN AstraZeneca $53.02 / +0.49 (+0.93%) A translation of a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $53.02 / +0.49 (+0.93%) 01/20/21 AstraZeneca's Enhertu approved in EU for HER2-positive metastatic breast cancer 01/18/21 AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer 01/15/21 Aveo Pharmaceuticals announces results from portion of DEDUCTIVE trial 01/15/21 AstraZeneca's Imfinzi approved in E.U. and U.K. for additional dosing in NSCLC AZN AstraZeneca $53.02 / +0.49 (+0.93%) 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 01/15/21 Berenberg AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Deutsche Bank AstraZeneca initiated with a Buy at Deutsche Bank AZN AstraZeneca $53.02 / +0.49 (+0.93%) 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year 07/30/20 AstraZeneca backs FY20 mid- to high-teens percentage increase in core EPS 07/30/20 AstraZeneca reports Q2 core EPS 96c, up 31% at CER AZN AstraZeneca $53.02 / +0.49 (+0.93%) 01/17/21 Pakistan approves AstraZeneca COVID vaccine for emergency use, Reuters says 01/15/21 AstraZeneca's COVISHIELD vaccine approved by Nepal, Reuters reports 01/03/21 AstraZeneca/Oxford COVID vaccine authorized by India, WSJ reports 12/30/20 U.S. EUA for AstraZeneca's COVID vaccine likely in April, Reuters reports AZN AstraZeneca $53.02 / +0.49 (+0.93%) 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/20/21 PDUFA Date for Tagrisso (Osimertinib) 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $53.02 / +0.49 (+0.93%) 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th 12/28/20 Unusually active option classes on open December 28th 12/14/20 AstraZeneca call volume above normal and directionally bullish

Options	Marathon Patent Group call volume above normal and directionally bullish » 10:25 01/22/21 01/22 10:25 01/22/21 10:25 MARA Marathon Patent Group $19.49 / +1.925 (+10.96%) Bullish option flow… Bullish option flow detected in Marathon Patent Group with 41,912 calls trading, 1.6x expected, and implied vol increasing almost 8 points to 201.65%. 1/22 weekly 19.5 calls and 1/22 weekly 20 calls are the most active options, with total volume in those strikes near 6,300 contracts. The Put/Call Ratio is 0.27. Earnings are expected on March 23rd. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options MARA Marathon Patent Group $19.49 / +1.925 (+10.96%) 01/19/21 Marathon Patent Group appoints Kevin DeNuccio to board of directors 01/13/21 Marathon Patent Group drops 19% to $21.10 after $250M registered direct offering 01/05/21 Marathon Patent Group, DMG Blockchain Solutions to form DCMNA 12/28/20 Marathon Patent Group announces purchase of 70,000 S-19 ASIC Miners MARA Marathon Patent Group $19.49 / +1.925 (+10.96%) 11/23/20 H.C. Wainwright Marathon Patent Group initiated with a Buy at H.C. Wainwright MARA Marathon Patent Group $19.49 / +1.925 (+10.96%) 11/12/20 Marathon Patent Group reports Q3 EPS (6c) vs (12c) last year 24 Jul MARA Marathon Patent Group $19.49 / +1.925 (+10.96%) 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 01/13/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: Wall Street's top stories for Monday MARA Marathon Patent Group $19.49 / +1.925 (+10.96%) 12/14/20 Marathon Patent Group call volume above normal and directionally bullish 11/23/20 Unusually active option classes on open November 23rd 11/18/20 Unusually active option classes on open November 18th
On The Fly	The Intersection: Crypto and Wall Street This Week » 09:39 01/22/21 01/22 09:39 01/22/21 09:39 BTC Bitcoin $0.00 / + (+0.00%) , BITCOIN Bitcoin $0.00 / + (+0.00%) , BLK BlackRock $742.10 / +0.41 (+0.06%) , COIN Coinbase $0.00 / + (+0.00%) , CLSK CleanSpark $25.20 / -3.08 (-10.89%) , RIOT Riot Blockchain $19.34 / -2.925 (-13.14%) , AMD AMD $91.52 / +2.76 (+3.11%) , NVDA Nvidia $554.67 / +19.64 (+3.67%) , OSTK Overstock.com $63.73 / +2.78 (+4.56%) , IDEX Ideanomics $3.17 / -0.09 (-2.76%) , TEUM Pareteum $0.27 / + (+0.00%) , SRAX Srax $3.08 / -0.1 (-3.14%) As bitcoin, ethereum and… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TEUM SRAX RIOT OSTK NVDA IDEX CLSK BTC BLK BITCOIN AMD TEUM Pareteum $0.27 / + (+0.00%) 12/14/20 Pareteum announces FY18 restated financial results 11/10/20 Pareteum issues letter to shareholders and provides business update 11/10/20 Pareteum to be delisted from Nasdaq SRAX Srax $3.08 / -0.1 (-3.14%) 12/31/20 SRAX extends right to receive BIGtoken special dividend till December 31, 2021 10/30/20 SRAX sells remaining MD ownership stake for $8M 10/01/20 Srax to move BIGtoken into its own public company RIOT Riot Blockchain $19.34 / -2.925 (-13.14%) 01/19/21 Riot Blockchain Expands S19 Pro Antminer fleet 12/28/20 Cryptocurrency mining related names rise after Bitcoin spike this weekend 12/14/20 Riot Blockchain announces 8 MW pilot project OSTK Overstock.com $63.73 / +2.78 (+4.56%) 01/12/21 Overstock.com says Echelon can now trade digital preferred shares 10/28/20 tZERO signs agreement with Tynton Capital to provide digitization services 10/28/20 Medici Ventures makes additional $8M equity purchase in Bitt NVDA Nvidia $554.67 / +19.64 (+3.67%) 01/10/21 Fly Intel: Top five weekend stock stories 01/10/21 Nio partners with Nvidia to develop new generation of automated driving EV 01/06/21 UK's CMA to investigate NVIDIA's takeover of Arm IDEX Ideanomics $3.17 / -0.09 (-2.76%) 01/15/21 Ideanomics announces MEG December, Q4 sales activity 01/05/21 Ideanomics to acquire Utah-based wireless charging provider WAVE 12/28/20 Ideanomics' MEG enters pruchase agreement for 2,000 units of BYD DI CLSK CleanSpark $25.20 / -3.08 (-10.89%) 01/21/21 CleanSpark says investigating short seller Culper Research, calls claims 'false' 01/20/21 CleanSpark generates just over 56 bitcoins as of Jan. 19 01/19/21 CleanSpark partnership announces new solar-plus-storage 01/13/21 CleanSpark announces additional residential microgrid contract BTC Bitcoin $0.00 / + (+0.00%) 01/13/21 DPW Holdings' DPL to provide business loans collateralized by bitcoin, Ethereum 01/11/21 Gundlach says Bitcoin in 'bubble territory' 01/08/21 Bill Miller says bitcoin should be up 50%-100% in next 12-18 months 01/07/21 MicroStrategy jumps 8% to $519.64 as bitcoin tops $40,000 for first time BLK BlackRock $742.10 / +0.41 (+0.06%) 01/21/21 BlackRock board approves 14% boost in quarterly dividend to $4.13 per share 01/14/21 BlackRock to make an investment in Clarity AI 01/14/21 BlackRock sees 2021 as-adjusted operating margin generally in line with 2020 01/14/21 BlackRock planning for possibility of lower securities lending revenue in 2021 BITCOIN Bitcoin $0.00 / + (+0.00%) 12/21/20 Riot Blockchain buys additional 15,000 Antminers from Bitmain for $35M 12/20/20 Tesla's Musk inquires about moving 'large transactions' to Bitcoin 12/17/20 Coinbase announces confidential submission of draft registration statement 12/03/20 Visa to launch credit card that rewards purchases in bitcoin AMD AMD $91.52 / +2.76 (+3.11%) 01/17/21 Fly Intel: Top five weekend stock stories 01/12/21 AMD announces ful portfolio of AMD Ryzen 5000 Series mobile processors 01/12/21 AMD shares slightly higher after CEO's keynote at CES 01/06/21 AMD promotes Darren Grasby to chief sales officer, Devinder Kumar to CFO BTC BITCOIN BLK COIN CLSK RIOT AMD NVDA OSTK IDEX TEUM SRAX BTC Bitcoin $0.00 / + (+0.00%) 01/13/21 Standpoint Research Bitcoin could hit $112,000 this year, says Standpoint Research 01/23/20 Morgan Stanley PayPal acceptance gap widens against Amazon, Bitcoin, says Morgan Stanley BITCOIN Bitcoin $0.00 / + (+0.00%) BLK BlackRock $742.10 / +0.41 (+0.06%) 01/19/21 RBC Capital PNC Financial price target raised to $161 from $135 at RBC Capital 01/15/21 BMO Capital BlackRock price target raised to $715 from $709 at BMO Capital 01/15/21 Deutsche Bank BlackRock price target raised to $838 from $835 at Deutsche Bank 01/15/21 Barclays BlackRock price target raised to $850 from $800 at Barclays COIN Coinbase $0.00 / + (+0.00%) CLSK CleanSpark $25.20 / -3.08 (-10.89%) 12/11/20 H.C. Wainwright CleanSpark price target raised to $24 from $18 at H.C. Wainwright RIOT Riot Blockchain $19.34 / -2.925 (-13.14%) 11/23/20 H.C. Wainwright Riot Blockchain price target raised to $7.50 from $3.50 at H.C. Wainwright AMD AMD $91.52 / +2.76 (+3.11%) 08:59 Today Truist Intel price target raised to $64 from $60 at Truist 01/14/21 Cowen AMD price target raised to $110 from $100 at Cowen 01/14/21 BMO Capital Intel upgraded to Outperform from Market Perform at BMO Capital 01/14/21 BMO Capital AMD downgraded to Underperform from Market Perform at BMO Capital NVDA Nvidia $554.67 / +19.64 (+3.67%) 01/15/21 Truist Nvidia price target raised to $672 from $643 at Truist 01/15/21 Susquehanna Nvidia price target raised to $625 from $610 at Susquehanna 01/12/21 Wells Fargo Nvidia very-well positioned as gaming momentum continues, says Wells Fargo 01/11/21 JPMorgan NIO Inc. price target raised to $75 from $50 at JPMorgan OSTK Overstock.com $63.73 / +2.78 (+4.56%) 11/02/20 Wedbush Overstock.com price target raised to $98 from $92 at Wedbush 11/02/20 Wedbush Overstock.com removed from Best Ideas List at Wedbush 10/30/20 Wedbush Overstock.com price target raised to $98 from $92 at Wedbush 10/30/20 Piper Sandler Overstock.com weakness a buying opportunity, says Piper Sandler IDEX Ideanomics $3.17 / -0.09 (-2.76%) TEUM Pareteum $0.27 / + (+0.00%) SRAX Srax $3.08 / -0.1 (-3.14%) 07/06/20 Fly Intel: Top five analyst initiations 07/06/20 B. Riley Securities B. Riley FBR starts Srax at Buy on 'rapid adoption' of Sequire 07/06/20 B. Riley Securities Srax initiated with a Buy at B. Riley FBR OSTK NVDA IDEX CLSK BTC BLK AMD OSTK Overstock.com $63.73 / +2.78 (+4.56%) 10/29/20 Overstock.com reports Q3 EPS 50c, two est. (23c) 07/30/20 Overstock.com reports Q2 EPS 84c, two est. (8c) NVDA Nvidia $554.67 / +19.64 (+3.67%) 11/18/20 Nvidia sees Q4 revenue $4.8B +/- 2%, consensus $4.42B 11/18/20 Nvidia reports Q3 EPS $2.91, consensus $2.57 11/18/20 Notable companies reporting after market close 08/19/20 Nvidia sees Q3 revenue $4.4B, plus or minus 2%, consensus $3.97B IDEX Ideanomics $3.17 / -0.09 (-2.76%) 12/02/20 Ideanomics' Treeletrik appoints Richard Teoh as CFO CLSK CleanSpark $25.20 / -3.08 (-10.89%) 10/21/20 CleanSpark backs FY21 revenue view $20M, consensus $22.87M 10/21/20 CleanSpark sees FY20 revenue over $10.0M, one estimate $10.22M BTC Bitcoin $0.00 / + (+0.00%) 07/23/20 Fly Intel: What to watch in credit card space earnings reports BLK BlackRock $742.10 / +0.41 (+0.06%) 01/14/21 BlackRock reports Q4 adjusted EPS $10.18, consensus $9.14 01/13/21 Notable companies reporting before tomorrow's open 10/13/20 BlackRock reports Q3 adjusted EPS $9.22, consensus $7.77 10/12/20 Notable companies reporting before tomorrow's open AMD AMD $91.52 / +2.76 (+3.11%) 10/27/20 AMD boosts FY20 revenue growth view to 41% vs. 2019, consensus $8.92B 10/27/20 AMD sees Q4 revenue approximately $3B, plus or minus $100M 10/27/20 AMD reports Q3 adjusted EPS 41c, consensus 35c 07/28/20 AMD sees FY20 revenue growth of approximately 32% 07 Oct 12 Aug 13 May OSTK NVDA CLSK BTC BLK BITCOIN AMD OSTK Overstock.com $63.73 / +2.78 (+4.56%) 12/22/20 Overstock eyes potential brick-and-mortar partnerships, AdWeek says NVDA Nvidia $554.67 / +19.64 (+3.67%) 12/11/20 Samsung seeing yield issues for 8nm process, DigiTimes reports 12/08/20 Intel, Nvidia asked about tech sale to China used against Uighurs, Reuters says CLSK CleanSpark $25.20 / -3.08 (-10.89%) 01/14/21 Culper Research issues short report on CleanSpark, calls stock 'uninvestible' 10/08/20 CleanSpark named as short idea by White Diamond Research BTC Bitcoin $0.00 / + (+0.00%) 01/21/21 BlackRock to make bitcoin futures eligible investment in two funds, Reuters says 01/20/21 Janet Yellen says cryptocurrencies used for illegal financing, BI says 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says 11/27/20 Coinbase faces claims of discrimination from Black workers, NYT reports BLK BlackRock $742.10 / +0.41 (+0.06%) 01/11/21 BlackRock selling stakes in sanctioned Chinese mobile companies, Bloomberg says 01/11/21 BlackRock pauses donations to public officials, Bloomberg reports 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says BITCOIN Bitcoin $0.00 / + (+0.00%) 10/22/20 PayPal in talks to acquire Bitcoin custodian BitGo, Bloomberg reports AMD AMD $91.52 / +2.76 (+3.11%) 01/16/21 Intel rebound will still take time, Barron's says 01/06/21 AMD's supply of Ryzen 3 notebook CPUs to fall short of demand, DigiTimes reports 12/20/20 Chip makers under threat from big tech companies, WSJ reports 11/24/20 Nvidia to support AMD mobility CPUs for high-end GPUs, WccfTech reports RIOT OSTK NVDA COIN CLSK BTC BLK AMD RIOT Riot Blockchain $19.34 / -2.925 (-13.14%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday OSTK Overstock.com $63.73 / +2.78 (+4.56%) 12/28/20 Fly Intel: Pre-market Movers NVDA Nvidia $554.67 / +19.64 (+3.67%) 01/16/21 Charged: NIO unveils new sedan, Plug partners with Renault 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla COIN Coinbase $0.00 / + (+0.00%) 01/17/21 Opening Day: Poshmark surges in debut, PetCo soars in return to market 01/10/21 Opening Day: Cullinan, Gracell surge in debut as SPAC craze continues CLSK CleanSpark $25.20 / -3.08 (-10.89%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 10/07/20 Fly Intel: Pre-market Movers BTC Bitcoin $0.00 / + (+0.00%) 09:39 Today The Intersection: Crypto and Wall Street This Week 01/15/21 The Intersection: Crypto and Wall Street This Week 01/08/21 The Intersection: Crypto and Wall Street This Week 12/18/20 The Intersection: Crypto and Wall Street This Week BLK BlackRock $742.10 / +0.41 (+0.06%) 01/14/21 Fly Intel: Pre-market Movers 12/06/20 Opening Day: Kinnate Biopharma soars in trading debut 10/13/20 Fly Intel: Wall Street's top stories for Tuesday AMD AMD $91.52 / +2.76 (+3.11%) 01/14/21 Fly Intel: Wall Street's top stories at midday 02/24/21 22nd Annual Virtual Financial Services Forum 01/26/21 AMD - AMD RIOT OSTK NVDA IDEX CLSK BLK AMD RIOT Riot Blockchain $19.34 / -2.925 (-13.14%) 01/14/21 Riot Blockchain call volume above normal and directionally bullish 12/22/20 Riot Blockchain call volume above normal and directionally bullish 12/04/20 Riot Blockchain call volume above normal and directionally bullish 11/23/20 Riot Blockchain call volume above normal and directionally bullish OSTK Overstock.com $63.73 / +2.78 (+4.56%) 01/12/21 Overstock com call volume above normal and directionally bullish 12/16/20 Unusually active option classes on open December 16th 12/15/20 Overstock com call volume above normal and directionally bullish 11/17/20 Overstock com call volume above normal and directionally bullish NVDA Nvidia $554.67 / +19.64 (+3.67%) 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains 10/06/20 Early notable gainers among liquid option names on October 6th IDEX Ideanomics $3.17 / -0.09 (-2.76%) 01/19/21 Largest borrow rate increases among liquid names 12/30/20 Largest borrow rate increases among liquid names 12/09/20 Largest borrow rate increases among liquid names 11/25/20 Unusual call flow in option market yesterday CLSK CleanSpark $25.20 / -3.08 (-10.89%) 01/11/21 Largest borrow rate increases among liquid names 12/10/20 CleanSpark call volume above normal and directionally bullish 12/10/20 Largest borrow rate increases among liquid names 10/30/20 Largest borrow rate increases among liquid names BLK BlackRock $742.10 / +0.41 (+0.06%) 10/13/20 Early notable gainers among liquid option names on October 13th AMD AMD $91.52 / +2.76 (+3.11%) 01/19/21 Notable open interest changes for January 19th 01/19/21 Advanced Micro put buyer realizes 22% same-day gains 01/15/21 Notable open interest changes for January 15th 01/14/21 Notable open interest changes for January 14th
Downgrade	Sage Therapeutics cut to Market Perform at BMO Capital on valuation » 06:56 01/22/21 01/22 06:56 01/22/21 06:56 SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/07/21 Sage Therapeutics plans to advance SAGE-319, SAGE-421 to preclinical studies 12/16/20 Sage Therapeutics names Barry Greene as CEO 11/27/20 Sage Therapeutics trading resumes 11/27/20 Sage Therapeutics to resume trading at 8 am ET SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 05:08 Today BMO Capital Sage Therapeutics downgraded to Market Perform from Outperform at BMO Capital 01/19/21 Wedbush Sage Therapeutics price target raised to $98 from $83 at Wedbush 01/04/21 Sage Therapeutics downgraded to Sector Perform at RBC Capital on valuation 01/04/21 Guggenheim Sage Therapeutics upgraded to Buy from Neutral at Guggenheim SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 11/05/20 Sage Therapeutics reports Q3 EPS ($2.03), consensus ($2.39) 08/10/20 Sage Therapeutics reports Q2 EPS ($2.63), consensus ($2.66) SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 12/04/20 Delta, United, Boeing downgrades among today's top calls on Wall Street 11/27/20 Fly Intel: Wall Street's top stories for Friday 11/27/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference
Downgrade	Sage Therapeutics downgraded to Market Perform from Outperform at BMO Capital » 05:08 01/22/21 01/22 05:08 01/22/21 05:08 SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) BMO Capital analyst Gary… BMO Capital analyst Gary Nachman downgraded Sage Therapeutics to Market Perform from Outperform with a $95 price target. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/07/21 Sage Therapeutics plans to advance SAGE-319, SAGE-421 to preclinical studies 12/16/20 Sage Therapeutics names Barry Greene as CEO 11/27/20 Sage Therapeutics trading resumes 11/27/20 Sage Therapeutics to resume trading at 8 am ET SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/19/21 Wedbush Sage Therapeutics price target raised to $98 from $83 at Wedbush 01/04/21 Sage Therapeutics downgraded to Sector Perform at RBC Capital on valuation 01/04/21 Guggenheim Sage Therapeutics upgraded to Buy from Neutral at Guggenheim 01/04/21 RBC Capital Sage Therapeutics downgraded to Sector Perform from Outperform at RBC Capital SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 11/05/20 Sage Therapeutics reports Q3 EPS ($2.03), consensus ($2.39) 08/10/20 Sage Therapeutics reports Q2 EPS ($2.63), consensus ($2.66) SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 12/04/20 Delta, United, Boeing downgrades among today's top calls on Wall Street 11/27/20 Fly Intel: Wall Street's top stories for Friday 11/27/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference

Yesterday
Hot Stocks	Moderna announces 1st participant dosed in Japan study of Moderna COVID vaccine » 09:05 01/21/21 01/21 09:05 01/21/21 09:05 MRNA Moderna $125.14 / +0.12 (+0.10%) , TAK Takeda Pharmaceutical $17.59 / +0.145 (+0.83%) Moderna (MRNA) announced… Moderna (MRNA) announced that the first participant has been dosed in the Phase 1/2 study of Moderna's vaccine candidate against COVID-19, mRNA-1273 or TAK-919, in Japan, led by Takeda Pharmaceutical (TAK). TAK-919 is Takeda's development code for Moderna's COVID-19 vaccine candidate. "We are pleased that this Phase 1/2 study of our COVID-19 vaccine in healthy adults in Japan has begun. This is the first clinical trial of a Moderna product in Japan and we thank Takeda for partnering with us to potentially protect the Japanese population from COVID-19 with a vaccine," said Stephane Bancel, Chief Executive Officer of Moderna. This placebo-controlled Phase 1/2 study will evaluate the safety and immunogenicity of two vaccinations of mRNA-1273 given 28 days apart. Takeda intends to enroll 200 participants aged 20 years and above in Japan. Each participant will be assigned to receive a placebo or a 100 undefined dose at both vaccinations. Participants will be followed through 12 months after the second vaccination. The ClinicalTrials.gov identifier is NCT04677660. Takeda and Moderna previously announced that Takeda will import and distribute 50 million doses of Moderna's COVID-19 vaccine candidate starting in the first half of 2021, pending licensure in Japan. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TAK MRNA TAK Takeda Pharmaceutical $17.59 / +0.145 (+0.83%) 12/18/20 Takeda confirms FDA approval of sNDA for Iclusig 12/16/20 Takeda Pharma, Prime Therapeutics sign arrangement for Hemophilia A treatment 12/15/20 FDA accept Takeda NDA for TAK-721, 'specifically' designed for EoE 12/09/20 Xenetic announces its partner reported data from study leveraging PolyXen MRNA Moderna $125.14 / +0.12 (+0.10%) 01/19/21 Moderna says cooperating with CDPH in probe of reports of adverse vaccine events 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 01/12/21 Moderna appoints Jose Vega as chief safety officer 01/12/21 Uber, Moderna to collaborate on 'uptake of COVID-19 vaccines' MRNA TAK MRNA Moderna $125.14 / +0.12 (+0.10%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/06/21 Piper Sandler Moderna price target raised to $170 after EU vaccine approval at Piper Sandler 01/04/21 Piper Sandler Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg TAK Takeda Pharmaceutical $17.59 / +0.145 (+0.83%) 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham 06/18/20 RBC Capital Neurocrine price target raised to $135 from $116 at RBC Capital 06/17/20 Oppenheimer Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer MRNA MRNA Moderna $125.14 / +0.12 (+0.10%) 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 10/28/20 Notable companies reporting before tomorrow's open 08/05/20 Moderna reports Q2 EPS (31c), consensus (35c) 19 May 12 Feb TAK MRNA TAK Takeda Pharmaceutical $17.59 / +0.145 (+0.83%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports 08/19/20 Takeda plans to sell OTC drug unit to Blackstone for $2.3B, Nikkei reports MRNA Moderna $125.14 / +0.12 (+0.10%) 01/20/21 McKesson to replace some Moderna vaccine shots shipped too cold, Bloomberg says 01/14/21 Moderna plans to test COVID-19 Vaccine booster shot, CNBC says 01/13/21 Moderna CEO says COVID-19 will be around 'forever,' CNBC says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports TAK MRNA TAK Takeda Pharmaceutical $17.59 / +0.145 (+0.83%) 08/24/20 Fly Intel: Wall Street's top stories for Monday 08/24/20 Fly Intel: Wall Street's top stories at midday 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers MRNA Moderna $125.14 / +0.12 (+0.10%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 MRNA MRNA Moderna $125.14 / +0.12 (+0.10%) 12/17/20 Moderna call volume above normal and directionally bullish 11/27/20 Moderna call buyer realizes 22% same-day gains 11/25/20 Moderna call volume above normal and directionally bullish 11/13/20 Unusually active option classes on open November 13th

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial